Suberoylanilide Hydroxamic Acid Treatment Reveals Crosstalks among Proteome, Ubiquitylome and Acetylome in Non-Small Cell Lung Cancer A549 Cell Line
Wu, Quan, Cheng, Zhongyi, Zhu, Jun, Xu, Weiqing, Peng, Xiaojun, Chen, Chuangbin, Li, Wenting, Wang, Fengsong, Cao, Lejie, Yi, Xingling, Wu, Zhiwei, Li, Jing, Fan, Pingsheng
Published in Scientific reports (31.03.2015)
Published in Scientific reports (31.03.2015)
Get full text
Journal Article
Closure of a secondary tracheoesophageal fistula in severe pneumonia using an Amplatzer Duct Occluder II during invasive mechanical ventilation: A case report
Fu, Meng, Wang, Dongsheng, Wang, Jialiang, Xu, Qixia, Cao, Lejie, Zhang, Junqiang
Published in Clinical case reports (01.10.2024)
Published in Clinical case reports (01.10.2024)
Get full text
Journal Article
Results from the IMpower132 China cohort: Atezolizumab plus platinum‐based chemotherapy in advanced non‐small cell lung cancer
Lu, Shun, Fang, Jian, Wang, Ziping, Fan, Yun, Liu, Yunpeng, He, Jianxing, Zhou, Jianying, Hu, Jie, Xia, Jinjing, Liu, Wenxin, Shi, Jane, Yi, Jing, Cao, Lejie
Published in Cancer medicine (Malden, MA) (01.02.2023)
Published in Cancer medicine (Malden, MA) (01.02.2023)
Get full text
Journal Article
Envonalkib versus crizotinib for treatment-naive ALK-positive non-small cell lung cancer: a randomized, multicenter, open-label, phase III trial
Yang, Yunpeng, Min, Jie, Yang, Nong, Yu, Qitao, Cheng, Ying, Zhao, Yanqiu, Li, Manxiang, Chen, Hong, Ren, Shou’an, Zhou, Jianying, Zhuang, Wu, Qin, Xintian, Cao, Lejie, Yu, Yan, Zhang, Jian, He, Jianxing, Feng, Jifeng, Yu, Hao, Zhang, Li, Fang, Wenfeng
Published in Signal transduction and targeted therapy (14.08.2023)
Published in Signal transduction and targeted therapy (14.08.2023)
Get full text
Journal Article
Pembrolizumab Plus Chemotherapy for Chinese Patients With Metastatic Squamous NSCLC in KEYNOTE-407
Cheng, Ying, Zhang, Li, Hu, Jie, Wang, Donglin, Hu, ChengPing, Zhou, Jianying, Wu, Lin, Cao, Lejie, Liu, Jiwei, Zhang, Helong, Sun, Hong, Wang, Ziping, Gao, Hongjun, Sun, Yuping, Li, Ben, Hu, Xiaohan, Schwarzenberger, Paul, Paz-Ares, Luis
Published in JTO clinical and research reports (01.10.2021)
Published in JTO clinical and research reports (01.10.2021)
Get full text
Journal Article
Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring MET exon 14 skipping alterations: a post hoc analysis of a pivotal phase 2 study
Yu, Yongfeng, Ren, Yongxin, Fang, Jian, Cao, Lejie, Liang, Zongan, Guo, Qisen, Han, Sen, Ji, Zimei, Wang, Ye, Sun, Yulan, Chen, Yuan, Li, Xingya, Xu, Hua, Zhou, Jianying, Jiang, Liyan, Cheng, Ying, Han, Zhigang, Shi, Jianhua, Chen, Gongyan, Ma, Rui, Fan, Yun, Sun, Sanyuan, Jiao, Longxian, Jia, Xiaoyun, Wang, Linfang, Lu, Puhan, Xu, Qian, Luo, Xian, Su, Weiguo, Lu, Shun
Published in Therapeutic advances in medical oncology (2022)
Published in Therapeutic advances in medical oncology (2022)
Get full text
Journal Article
Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy
Wu, Fengying, Jiang, Tao, Chen, Gongyan, Huang, Yunchao, Zhou, Jianying, Lin, Lizhu, Feng, Jifeng, Wang, Zhehai, Shu, Yongqian, Shi, Jianhua, Hu, Yi, Wang, Qiming, Cheng, Ying, Chen, Jianhua, Lin, Xiaoyan, Wang, Yongsheng, Huang, Jianan, Cui, Jiuwei, Cao, Lejie, Liu, Yunpeng, Zhang, Yiping, Pan, Yueyin, Zhao, Jun, Wang, LiPing, Chang, Jianhua, Chen, Qun, Ren, Xiubao, Zhang, Wei, Fan, Yun, He, Zhiyong, Fang, Jian, Gu, Kangsheng, Dong, Xiaorong, Zhang, Tao, Shi, Wei, Zou, Jianjun, Bai, Xuejuan, Ren, Shengxiang, Zhou, Caicun
Published in Cancer communications (London, England) (01.12.2022)
Published in Cancer communications (London, England) (01.12.2022)
Get full text
Journal Article
Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring MET Exon 14 Skipping Alterations
Lu, Shun, Fang, Jian, Li, Xingya, Cao, Lejie, Zhou, Jianying, Guo, Qisen, Liang, Zongan, Cheng, Ying, Jiang, Liyan, Yang, Nong, Han, Zhigang, Shi, Jianhua, Chen, Yuan, Xu, Hua, Zhang, Helong, Chen, Gongyan, Ma, Rui, Sun, Sanyuan, Fan, Yun, Fan, Songhua, Yu, Jie, Lu, Puhan, Luo, Xian, Su, Weiguo
Published in JTO clinical and research reports (01.10.2022)
Published in JTO clinical and research reports (01.10.2022)
Get full text
Journal Article
Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial
Lu, Shun, Pan, Hongming, Wu, Lin, Yao, Yu, He, Jianxing, Wang, Yan, Wang, Xiuwen, Fang, Yong, Zhou, Zhen, Wang, Xicheng, Cai, Xiuyu, Yu, Yan, Ma, Zhiyong, Min, Xuhong, Yang, Zhixiong, Cao, Lejie, Yang, Huaping, Shu, Yongqian, Zhuang, Wu, Cang, Shundong, Fang, Jian, Li, Kai, Yu, Zhuang, Cui, Jiuwei, Zhang, Yang, Li, Man, Wen, Xinxuan, Zhang, Jie, Li, Weidong, Shi, Jianhua, Xu, Xingxiang, Zhong, Diansheng, Wang, Tao, Zhu, Jiajia
Published in Signal transduction and targeted therapy (30.06.2023)
Published in Signal transduction and targeted therapy (30.06.2023)
Get full text
Journal Article
Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib‐refractory ALK‐positive NSCLC from a phase II study
Zheng, Jing, Wang, Tao, Yang, Yunpeng, Huang, Jie, Feng, Jifeng, Zhuang, Wu, Chen, Jianhua, Zhao, Jun, Zhong, Wei, Zhao, Yanqiu, Zhang, Yiping, Song, Yong, Hu, Yi, Yu, Zhuang, Gong, Youling, Chen, Yuan, Ye, Feng, Zhang, Shucai, Cao, Lejie, Fan, Yun, Wu, Gang, Guo, Yubiao, Zhou, Chengzhi, Ma, Kewei, Fang, Jian, Feng, Weineng, Liu, Yunpeng, Zheng, Zhendong, Li, Gaofeng, Wang, Huijie, Cang, Shundong, Wu, Ning, Song, Wei, Liu, Xiaoqing, Zhao, Shijun, Ding, Lieming, Selvaggi, Giovanni, Wang, Yang, Xiao, Shanshan, Wang, Qian, Shen, Zhilin, Zhou, Jianya, Zhou, Jianying, Zhang, Li
Published in Cancer communications (London, England) (01.04.2024)
Published in Cancer communications (London, England) (01.04.2024)
Get full text
Journal Article
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
Zhou, Caicun, Wang, Ziping, Sun, Yuping, Cao, Lejie, Ma, Zhiyong, Wu, Rong, Yu, Yan, Yao, Wenxiu, Chang, Jianhua, Chen, Jianhua, Zhuang, Wu, Cui, Jiuwei, Chen, Xueqin, Lu, You, Shen, Hong, Wang, Jingru, Li, Peiqi, Qin, Mengmeng, Lu, Dongmei, Yang, Jason
Published in The lancet oncology (01.02.2022)
Published in The lancet oncology (01.02.2022)
Get full text
Journal Article
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Wang, Jie, Zhou, Caicun, Yao, Wenxiu, Wang, Qiming, Min, Xuhong, Chen, Gongyan, Xu, Xingxiang, Li, Xingya, Xu, Fei, Fang, Yong, Yang, Runxiang, Yu, Guohua, Gong, Youling, Zhao, Jun, Fan, Yun, Liu, Quan, Cao, Lejie, Yao, Yu, Liu, Yunpeng, Li, Xiaoling, Wu, Jingxun, He, Zhiyong, Lu, Kaihua, Jiang, Liyan, Hu, Chengping, Zhao, Wenhua, Zhang, Ben, Shi, Wei, Zhang, Xiaojing, Cheng, Ying, Cheng, Ying, Wang, Jie, Zhou, Caicun, Yao, Wenxiu, Wang, Qiming, Min, Xuhong, Chen, Gongyan, Xu, Xingxiang, Li, Xingya, Xu, Fei, Fang, Yong, Yang, Runxiang, Yu, Guohua, Gong, Youling, Zhao, Jun, Fan, Yun, Liu, Quan, Cao, Lejie, Yao, Yu, Liu, Yunpeng, Li, Xiaoling, Wu, Jingxun, He, Zhiyong, Lu, Kaihua, Jiang, Liyan, Hu, Chengping, Zhao, Wenhua, Yu, Huiqing, Zhao, Jian, Wu, Gang, Huang, Dingzhi, Chen, Chengshui, Ding, Cuimin, Zhang, Baihong, Wang, Xiuwen, Luo, Hui, Li, Baolan, Zhang, Shucai, Lu, Hong, Shi, Meiqi, Chen, Xi, Guo, Yubiao, Liu, Hailong, Liu, Jiwei, Gao, Hongjun, Hu, Sheng, Hong, Qunying, Li, Qi, Zhang, Ben, Shi, Wei, Zhang, Xiaojing
Published in The lancet oncology (01.06.2022)
Published in The lancet oncology (01.06.2022)
Get full text
Journal Article
Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study
Lu, Shun, Fang, Jian, Li, Xingya, Cao, Lejie, Zhou, Jianying, Guo, Qisen, Liang, Zongan, Cheng, Ying, Jiang, Liyan, Yang, Nong, Han, Zhigang, Shi, Jianhua, Chen, Yuan, Xu, Hua, Zhang, Helong, Chen, Gongyan, Ma, Rui, Sun, Sanyuan, Fan, Yun, Li, Jing, Luo, Xian, Wang, Linfang, Ren, Yongxin, Su, Weiguo
Published in The lancet respiratory medicine (01.10.2021)
Published in The lancet respiratory medicine (01.10.2021)
Get more information
Journal Article
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
Zhou, Caicun, Chen, Gongyan, Huang, Yunchao, Zhou, Jianying, Lin, LiZhu, Feng, Jifeng, Wang, Zhehai, Shu, Yongqian, Shi, Jianhua, Hu, Yi, Wang, QiMing, Cheng, Ying, Wu, Fengying, Chen, Jianhua, Lin, Xiaoyan, Wang, Yongsheng, Huang, Jianan, Cui, Jiuwei, Cao, Lejie, Liu, Yunpeng, Zhang, Yiping, Pan, Yueyin, Zhao, Jun, Wang, LiPing, Chang, Jianhua, Chen, Qun, Ren, Xiubao, Zhang, Wei, Fan, Yun, He, Zhiyong, Fang, Jian, Gu, Kangsheng, Dong, XiaoRong, Zhang, Tao, Shi, Wei, Zou, Jianjun
Published in The lancet respiratory medicine (01.03.2021)
Published in The lancet respiratory medicine (01.03.2021)
Get more information
Journal Article
Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study
Shi, Yuankai, Chen, Gongyan, Wang, Xiang, Liu, Yunpeng, Wu, Lin, Hao, Yanrong, Liu, Chunling, Zhu, Shuyang, Zhang, Xiaodong, Li, Yuping, Liu, Jiwei, Cao, Lejie, Cheng, Ying, Zhao, Hui, Zhang, Shucai, Zang, Aimin, Cui, Jiuwei, Feng, Jian, Yang, Nong, Liu, Fei, Jiang, Yong, Gu, Chuan
Published in The lancet respiratory medicine (01.11.2022)
Published in The lancet respiratory medicine (01.11.2022)
Get more information
Journal Article
Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial
Yang, Yunpeng, Zhou, Jianya, Zhou, Jianying, Feng, Jifeng, Zhuang, Wu, Chen, Jianhua, Zhao, Jun, Zhong, Wei, Zhao, Yanqiu, Zhang, Yiping, Song, Yong, Hu, Yi, Yu, Zhuang, Gong, Youling, Chen, Yuan, Ye, Feng, Zhang, Shucai, Cao, Lejie, Fan, Yun, Wu, Gang, Guo, Yubiao, Zhou, Chengzhi, Ma, Kewei, Fang, Jian, Feng, Weineng, Liu, Yunpeng, Zheng, Zhendong, Li, Gaofeng, Wu, Ning, Song, Wei, Liu, Xiaoqing, Zhao, Shijun, Ding, Lieming, Mao, Li, Selvaggi, Giovanni, Yuan, Xiaobin, Fu, Yuanqing, Wang, Tao, Xiao, Shanshan, Zhang, Li
Published in The lancet respiratory medicine (01.01.2020)
Published in The lancet respiratory medicine (01.01.2020)
Get more information
Journal Article
Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M-positive Non-Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study
Xing, Ligang, Pan, Yueyin, Shi, Yuankai, Shu, Yongqian, Feng, Jifeng, Li, Wei, Cao, Lejie, Wang, Lifeng, Gu, Wei, Song, Yong, Xing, Puyuan, Liu, Yutao, Gao, Wen, Cui, Jiuwei, Hu, Nana, Li, Rutian, Bao, Hua, Shao, Yang, Yu, Jinming
Published in Clinical cancer research (01.12.2020)
Published in Clinical cancer research (01.12.2020)
Get full text
Journal Article